Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pneumonia × Prednisone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 101 Lymphoma, Large B-Cell, Diffuse 91 Lymphoma 78 Precursor Cell Lymphoblastic Leukemia-Lymphoma 51 Lymphoma, Follicular 35 Burkitt Lymphoma 34 Lymphoma, Non-Hodgkin 33 Leukemia 29 Multiple Myeloma 26 Hodgkin Disease 24 Lymphoma, Mantle-Cell 23 Lymphoma, T-Cell, Peripheral 18 Lymphoma, Large-Cell, Immunoblastic 15 Neoplasm Metastasis 13 Lymphoma, Large-Cell, Anaplastic 13 Lymphoma, B-Cell, Marginal Zone 13 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11 Neoplasms, Plasma Cell 11 Lymphoma, B-Cell 11 Leukemia, Lymphocytic, Chronic, B-Cell 11 Immunoblastic Lymphadenopathy 10 Recurrence 9 Dendritic Cell Sarcoma, Interdigitating 8 Blast Crisis 7 Neoplasms 6 Enteropathy-Associated T-Cell Lymphoma 6 Waldenstrom Macroglobulinemia 5 Primary Myelofibrosis 5 Myasthenia Gravis 5 Leukemia, Myeloid, Acute 5

Interventions

Methylprednisolone 2 Bronchoscopy 2 Bronchoalveolar Lavage 2 ziprasidone 1 pirfenidone 1 ceftolozane, tazobactam drug combination 1 Zolpidem 1 XAV-19 1 X-Rays 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Ultrasonography 1 Tranexamic Acid 1 Tobramycin 1 Thoracotomy 1 Thoracic Surgery, Video-Assisted 1 Surveys and Questionnaires 1 Standard of Care 1 Spironolactone 1 Sodium Bicarbonate 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Ribavirin 1 Prednisone 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04036721 2023-02-23

PROS-CONS

National Institute for Tuberculosis and Lung Diseases, Poland

Phase 4 Suspended

Lung Neoplasms, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡